Fresh analysis indicates that people who discontinue popular GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt conventional lifestyle plans.
Research printed in a prominent health publication shows that while obese people often shed substantial amounts of their body weight while on the medication, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Users purchasing such treatments must be aware of the potential of quick weight regain when the therapy is stopped," cautioned expert Dr. Susan Jebb.
That rate of regain implies a return to original mass within about 18 months.
Comparing Approaches
The study, which looked at 37 of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with conventional dieting.
Researchers note that people who shed pounds through lifestyle changes alone typically have a more gradual weight regain—approximately 0.1 kg a month—post-intervention.
Explaining the Rapid Rebound
Experts suggest the way of the drugs accounts for the accelerated rebound.
These medications imitate a natural hormone called GLP-1, which controls feelings of fullness.
"Long-term administration of the hormone levels several times higher than the body's typical production could lead to the system to produce less of its own natural hormone, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics expert.
"Stopping of this hormone supplement means hunger is unsuppressed, making excessive eating much more probable."
A Lifelong Issue?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, considering the significant potential of relapse, the treatment should be considered long-term.
This view is echoed by drug manufacturers, who say that the results "underscore the chronic nature of excess weight," similar to managing diseases like hypertension.
User Experiences
People who have come off the medication describe a intense return of cravings.
"It was like a trigger activating and you're instantly extremely hungry," recalled an individual.
This difficulty is compounded if patients have not developed sustainable lifestyle or habit modifications during treatment.
Widespread Interest
Figures suggest that a significant number of people in the UK have used these injections in the last 12 months, with desire remaining high.
- Adoption is greater among women than men.
- The middle-aged demographic shows the highest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a standalone cure and maintained weight loss hinges on combined lifestyle management.
